Form 4: MACOM SVP Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


MACOM Technology Solutions Holdings' SVP of Operations, Robert Dennehy, sold 4,128 shares of common stock for a weighted average price of $140.02 per share under a pre-arranged 10b5-1 plan.

Summary

  • Robert Dennehy, SVP of Operations at MACOM Technology Solutions Holdings, Inc. (MTSI), reported a sale of common stock.
  • The transaction involved the disposition of 4,128 shares of MACOM common stock.
  • The shares were sold on October 16, 2025, at a weighted average price of $140.02 per share.
  • The sale was executed pursuant to a Rule 10b5-1 sales plan adopted by Mr. Dennehy on February 28, 2025.
  • Following this transaction, Mr. Dennehy beneficially owns 6,552 shares of MACOM common stock directly.
  • The selling price ranged from $140.00 to $140.08 per share.

Sentiment

Score: 5

Explanation: The transaction represents a planned sale of shares by a senior executive under a Rule 10b5-1 plan, which is a neutral event in itself. While it reduces insider ownership, the pre-scheduled nature mitigates concerns about opportunistic selling.

Positives

  • The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a structured and pre-scheduled transaction rather than a reaction to immediate market events. This enhances transparency and mitigates concerns about opportunistic insider trading.

Negatives

  • A senior executive, Robert Dennehy, reduced his direct beneficial ownership in the company by 4,128 shares.
  • The transaction resulted in a decrease in the total number of shares held by a key insider, which could be interpreted by some investors as a reduction in confidence, despite the 10b5-1 plan.

Risks

  • No specific risks to the company's operations or financial health are mentioned. The primary 'risk' from an investor perspective is the potential negative signal of insider selling, though mitigated by the 10b5-1 plan.

Future Outlook

NA

Management Comments

  • The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 28, 2025 and intended to comply with Rule 10b5-1 under The Securities Exchange Act of 1934.
  • The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

Insider transactions, particularly sales by executives, are common occurrences in publicly traded companies. The use of a Rule 10b5-1 plan is a standard practice for executives to sell shares in a pre-scheduled manner, mitigating concerns about trading on material non-public information. This transaction is typical for an executive managing personal liquidity or portfolio diversification.

Comparison to Industry Standards

  • NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceThe sale was conducted under a Rule 10b5-1 plan, adopted on February 28, 2025, demonstrating adherence to corporate governance best practices for insider trading by pre-scheduling transactions.2025-10-16Enhances transparency and reduces the risk of actual or perceived insider trading, aligning executive share sales with regulatory compliance.

Stakeholder Impact

  • Shareholders: May view the reduction in insider ownership with slight caution, though the 10b5-1 plan provides context. The transparency of the plan is generally positive.

Next Steps

  • NA

Key Dates

DateDescription
2025-02-28Date Reporting Person adopted the Rule 10b5-1 sales plan.
2025-10-16Date of transaction (sale of common stock).
2025-10-20Date Form 4 was signed and filed.

Keywords

MACOM Technology Solutions Holdings, MTSI, Robert Dennehy, Form 4, insider trading, 10b5-1 plan, stock sale, executive compensation, beneficial ownership, semiconductor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.